Local Institution

Little Rock, Arkansas 72205

0 studies enrolling now · 28 studies all time

What they study most

Acute Coronary Syndromes, Bipolar Disorder, Bipolar I Disorder, Body Weight Change, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Congestive Heart Failure, Diabetes Mellitus, Diabetes Mellitus II, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Type 2, Dyslipidemia

Studies at this site

• Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
• A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease — Completed
• A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel — Withdrawn before enrolling
• Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone — Completed
• Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) — Completed
• Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
• Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode — Completed
• Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder — Completed
• Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder — Completed
• Study of Aripiprazole in Patients With Bipolar I Disorder — Completed
• Aripiprazole Open-Label, Safety and Tolerability Study — Completed
• Aripiprazole in Adolescents With Schizophrenia — Completed
• Aripiprazole in Children and Adolescents With Bipolar I Disorder — Completed
• PPAR - Combination With Metformin — Completed
• Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia — Completed
• Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen — Completed
• A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes — Completed
• Atazanavir for HIV Infected Individuals: An Early Access Program — NO_LONGER_AVAILABLE
• Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone — Completed
• A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics — Completed
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed
• PPAR-COMBO With Sulfonylurea — Completed
• BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery — Completed
• Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies — Stopped early
• Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen — Completed
• A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen — Completed
• A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy — Stopped early